The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism-Reference-Cited by-同舟云学术

The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism

Published:2020-03-03 Issue:4 Volume:14 Page:259-270
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Chen Liping¹,Huang Weifang²,Wang Ling³⁴,Zhang Zili³⁴,Zhang Feng³⁴,Zheng Shizhong³⁴,Kong Desong¹

Affiliation:

1. Chinese Medicine Modernization and Big Data Research Center, Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China

2. Department of Pharmacology, School of Integral Medicine, Nanjing University of Chinese Medicine, Nanjing, China

3. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China

4. Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2020.1736042

Reference145 articles.

1. Encapsulated Curcumin Enhances Intestinal Absorption and Improves Hepatic Damage in Alcoholic Liver Disease-Induced Rats

2. Welches (ist das richtige) Target bei nichtalkoholischer Fettleber (NAFLD)

3. Hepatitis C virus-induced hepatocellular carcinoma: a narrative review

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting histone methylation and demethylation for non-alcoholic fatty liver disease;Bioorganic Chemistry;2024-10

2. A comprehensive insight into the contribution of epigenetics in male infertility; focusing on immunological modifications;Journal of Reproductive Immunology;2024-08

3. H3K18 lactylation accelerates liver fibrosis progression through facilitating SOX9 transcription;Experimental Cell Research;2024-07

4. Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight;Metabolites;2024-06-08

5. Liver‐specific deletion of de novo DNA methyltransferases protects against glucose intolerance in high‐fat diet‐fed male mice;The FASEB Journal;2024-05-25